| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.13▼ | 2.13▼ | 2.14▼ | 2.09▲ | 2.20▼ |
| MA10 | 2.12▲ | 2.10▲ | 2.09▲ | 2.22▼ | 2.31▼ |
| MA20 | 2.09▲ | 2.10▲ | 2.13▼ | 2.26▼ | 3.29▼ |
| MA50 | 2.15▼ | 2.25▼ | 2.26▼ | 2.30▼ | 2.88▼ |
| MA100 | 2.28▼ | 2.24▼ | 2.25▼ | 3.76▼ | 1.97▲ |
| MA200 | 2.27▼ | 2.30▼ | 2.41▼ | 3.10▼ | 115.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | 0.017▲ | 0.012▲ | -0.003▼ | -0.196▼ |
| RSI | 50.316▲ | 45.600▼ | 44.142▼ | 44.009▼ | 41.990▼ |
| STOCH | 78.143 | 82.474▲ | 78.784 | 20.736 | 18.627▼ |
| WILL %R | -25.000▲ | -25.000▲ | -29.412 | -77.586▼ | -84.520▼ |
| CCI | 43.455 | 53.840 | 42.739 | -78.837 | -62.239 |
|
Wednesday, May 14, 2025 08:19 AM
Ensysce Biosciences (NASDAQ:ENSC) is a clinical stage company that is developing novel opioids that provide the needed pain relief, while greatly limiting the potential for abuse and overdoses ...
|
|
Tuesday, May 13, 2025 01:15 PM
SAN DIEGO, CA / ACCESS Newswire / May 13, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage pharmaceutical company developing innovative solutions for ...
|
|
Saturday, April 19, 2025 01:08 AM
Short interest in Ensysce Biosciences Inc (NASDAQ:ENSC) increased during the last reporting period, rising from 144.54K to 344.43K. This put 14.69% of the company's publicly available shares short.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 2.12 | 2.12 | 2.12 | 2.12 | 32,042 |
| 13/06/25 | 2.06 | 2.14 | 2.05 | 2.07 | 46,754 |
| 12/06/25 | 2.09 | 2.17 | 2.04 | 2.14 | 53,530 |
| 11/06/25 | 2.10 | 2.15 | 1.99 | 2.065 | 129,698 |
| 10/06/25 | 2.27 | 2.31 | 2.025 | 2.04 | 222,689 |
| 09/06/25 | 2.42 | 2.4699 | 2.26 | 2.33 | 79,868 |
| 06/06/25 | 2.35 | 2.5197 | 2.29 | 2.38 | 80,843 |
| 05/06/25 | 2.35 | 2.4673 | 2.26 | 2.34 | 205,076 |
| 04/06/25 | 2.18 | 2.57 | 2.12 | 2.38 | 3,313,950 |
| 03/06/25 | 2.20 | 2.3299 | 2.20 | 2.30 | 46,132 |
|
|
||||
|
|
||||
|
|